Gain Therapeutics Inc (GANX) Stock Price

2.18 ▲ +0.13 (+6.34%)
Open: 2.10 Vol: 929.48K Day's range: 2.0101 - 2.25 May 01, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
GANX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.19▼ 2.19▼ 2.17▲ 1.99▲ 1.84▲
MA10 2.20▼ 2.16▲ 2.11▲ 1.91▲ 1.96▲
MA20 2.20▼ 2.07▲ 2.01▲ 1.80▲ 2.09▲
MA50 2.15▲ 1.97▲ 1.92▲ 1.97▲ 1.84▲
MA100 2.04▲ 1.89▲ 1.82▲ 2.04▲ 2.71▼
MA200 1.96▲ 1.79▲ 1.90▲ 1.85▲ 3.78▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.008▼ 0.008▲ 0.020▲ 0.054▲ -0.023▼
RSI 45.798▼ 69.292▲ 70.560▲ 63.489▲ 52.680▲
STOCH 14.074▼ 84.038▲ 90.814▲ 80.006▲ 30.188    
WILL %R -100.000▼ -28.889     -17.808▲ -9.859▲ -47.372    
CCI -214.756▼ 69.257     93.068     219.663▲ 2.450    
Latest Filters Detected On GANX
▲ MACD $GANX MACD(12,26,9) Crossed Above Zero Set Alert
▲ GAP $GANX Open Gap Up %2 Set Alert
▲ BREAK $GANX Price Breaks 20 Days High Set Alert
▲ BREAK $GANX Price Breaks 10 Days High Set Alert
Gain Therapeutics Inc News
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on ...
Wednesday, April 30, 2025 04:46 AM
BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation ...
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson’s Disease and Related Disorders
Wednesday, April 30, 2025 04:45 AM
Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule ...
Gain Therapeutics Announces Oral Poster Presentation at IAPRD 2025 30th World Congress on Parkinson's Disease and Related Disorders
Tuesday, April 29, 2025 04:59 PM
BETHESDA, Md., April 30, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain”, or the "Company”), a clinical-stage biotechnology company leading the discovery and development of the ...
GANX historical stock data
date open high low close volume
01/05/25 2.10 2.25 2.0101 2.18 929,482
30/04/25 1.89 2.09 1.838 2.05 599,186
29/04/25 1.90 1.94 1.88 1.90 429,825
28/04/25 1.89 1.96 1.84 1.91 310,804
25/04/25 1.88 1.949 1.8384 1.895 247,931
24/04/25 1.87 1.8949 1.82 1.88 188,348
23/04/25 1.88 1.9878 1.81 1.85 287,114
22/04/25 1.78 1.87 1.72 1.85 206,520
21/04/25 1.77 1.81 1.67 1.74 205,550
17/04/25 1.75 1.82 1.70 1.80 149,571
Quote Details
52wk Low:0.89
52wk High:3.19
Vol:929.48K
Avg Vol(3m):4.1M
1Y Chng:-18.20%
1M Chng:-4.80%
Add to Watch List
More Information
Index US Composite
Market Cap. 56.96M